Moleculin Biotech Inc [NASDAQ: MBRX] closed the trading session at $1.27.
The stocks have a year to date performance of -25.29 percent and weekly performance of 51.12 percent. The stock has been moved at -45.96 percent over the last six months. The stock has performed -32.09 percent around the most recent 30 days and changed -49.40 percent over the most recent 3-months.
If compared to the average trading volume of 158.53K shares, MBRX reached to a volume of 103313193 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Moleculin Biotech Inc [MBRX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBRX shares is $28.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBRX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Moleculin Biotech Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on February 12, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on July 18, 2022, representing the official price target for Moleculin Biotech Inc stock.
The Average True Range (ATR) for Moleculin Biotech Inc is set at 0.39 The Price to Book ratio for the last quarter was 0.51, with the Price to Cash per share for the same quarter was set at 2.26.
MBRX stock trade performance evaluation
Moleculin Biotech Inc [MBRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 51.12. With this latest performance, MBRX shares dropped by -32.09% in over the last four-week period, additionally sinking by -45.96% over the last 6 months – not to mention a drop of -83.62% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBRX stock in for the last two-week period is set at 48.07, with the RSI for the last a single of trading hit 53.90, and the three-weeks RSI is set at 45.11 for Moleculin Biotech Inc [MBRX]. The present Moving Average for the last 50 days of trading for this stock 1.7543, while it was recorded at 0.7399 for the last single week of trading, and 2.8853 for the last 200 days.
Moleculin Biotech Inc [MBRX]: An insightful look at the core fundamentals
Moleculin Biotech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.08 and a Current Ratio set at 2.08.
Earnings per share (EPS) analysis for Moleculin Biotech Inc [MBRX] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MBRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Moleculin Biotech Inc go to 36.38%.
